» Articles » PMID: 2713503

A C----T Substitution at Nt--101 in a Conserved DNA Sequence of the Promotor Region of the Beta-globin Gene is Associated with "silent" Beta-thalassemia

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1989 May 1
PMID 2713503
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Sequence analyses and dot-blot analyses with synthetic oligonucleotide probes have identified eight individuals in three Turkish families and one Bulgarian family with one chromosome having a C----T mutation at nucleotide position--101 relative to the Cap site of the beta-globin gene. This nucleotide is part of one of the conserved blocks of nucleotides within the promoter region; in vitro expression analyses with the chloramphenicol acetyltransferase system showed that this substitution will decrease the effectiveness of transcription. Five subjects had a thalassemia intermedia due to the additional presence of a known classical high hemoglobin (Hb) A2 beta-thalassemia mutation on the second chromosome; their hematologic condition was relatively mild. The three persons with a heterozygosity for the--101 C----T mutation had normal hematologic data without microcytosis but with high-normal levels of Hb A2 and a mild imbalance in chain synthesis. The newly discovered mutation is considered one of the silent types of beta-thalassemia. It is relatively rare because it was absent among several hundred normal and beta-thalassemia chromosomes.

Citing Articles

Computational Analysis of Protein Structure Changes as a Result of Nondeletion Insertion Mutations in Human -Globin Gene Suggests Possible Cause of -Thalassemia.

Qadah T, Jamal M Biomed Res Int. 2019; 2019:9210841.

PMID: 31275994 PMC: 6582885. DOI: 10.1155/2019/9210841.


Molecular basis of β thalassemia and potential therapeutic targets.

Thein S Blood Cells Mol Dis. 2017; 70:54-65.

PMID: 28651846 PMC: 5738298. DOI: 10.1016/j.bcmd.2017.06.001.


The molecular basis of β-thalassemia.

Thein S Cold Spring Harb Perspect Med. 2013; 3(5):a011700.

PMID: 23637309 PMC: 3633182. DOI: 10.1101/cshperspect.a011700.


The prevention of thalassemia.

Cao A, Kan Y Cold Spring Harb Perspect Med. 2013; 3(2):a011775.

PMID: 23378598 PMC: 3552345. DOI: 10.1101/cshperspect.a011775.


The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes.

Touhami I, Fattoum S, Bibi A, Siala H, Messaoud T, Koubaa D Eur J Appl Physiol. 2009; 108(6):1075-81.

PMID: 20013288 DOI: 10.1007/s00421-009-1314-0.